Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology (ISH, Digital Pathology), By Application (Breast Cancer, Prostate Cancer), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Research Methodology

A three-pronged approach was followed for deducing the tissue diagnostics market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for tissue diagnostics market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of tissue diagnostics market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Tissue Diagnostics Market Categorization:

The tissue diagnostics market was categorized into four segments, namely technology (Immunohistochemistry, In Situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology), application (Breast Cancer, Non-small Cell Lung Cancer, Prostate Cancer, Gastric Cancer), end-use (Hospitals, Research Laboratories, Pharmaceutical Organizations, Contract Research Organizations), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The tissue diagnostics market was segmented into technology, application, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The tissue diagnostics market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-four countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Singapore; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; and Kuwait

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Tissue diagnostics market companies & financials:

The tissue diagnostics market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• F. HOFFMANN-LA ROCHE LTD - F. Hoffmann-La Roche AG is a multinational healthcare company that functions in two segments, namely, pharmaceuticals and diagnostics. The company is involved in R&D & production of test kits, molecular diagnostic reagents, and test systems. In addition, it offers automated instruments, IT solutions, software, and consumables, which are expansively utilized in in vitro research & diagnostics. The company supplies to hospitals, private medical laboratories, research laboratories, patients, and practicing doctors and physicians. AT present, it runs as a subsidiary of Roche Holding AG and is present in over 100 nations. 

• ABBOTT - Abbott is a healthcare company engaged in development of products and technologies. The company operates in major healthcare sectors such as medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals. Its diagnostics segment offers a broad product portfolio: immunoassay, hematology, clinical chemistry, blood screening, point-of-care, and informatics. The company also offers Abbott PRISM, a brand in the blood screening segment. The company has presence in North America, Europe, and Asia Pacific. In September 2017, Abbott completed the acquisition of Alere, Inc. to expand its diagnostics business. 

• ALERE - Alere, Inc. is a publicly owned company that offers rapid diagnostic tests for better clinical and healthcare outcomes. The company offers services in cardio metabolism, infectious diseases, toxicology, clinical immunology, oncology, and women’s health. The company was previously known as SelfCare. It changed its name to Inverness Medical Technology in 2000 and again to Alere in 2010. It expanded its business following the acquisition of companies such as Clondiag, TwistDx, Ostex International, Standard Diagnostics, Axis-Shield, Ionian Technologies, Wampole Laboratories, Binax, and Biosite. It has various business segments including health information solutions, consumer diagnostics, and professional diagnostics. 

• SIEMENS HEALTHINEERS - Siemens Healthineers AG was formerly known as Siemens Healthcare. It manufactures and provides clinical diagnostics and therapeutic systems. The company operates in three divisions: diagnostics, imaging, and advanced therapies. The diagnostics division provides in vitro diagnostic products or services for molecular, laboratory, and diagnostics. Its imaging division offers magnetic resonance imaging, X-ray systems, computed tomography, ultrasound equipment, molecular imaging, and related software solutions. The advanced therapies division offers integrated solutions, products, and services across multiple clinical fields. 

• DANAHER CORPORATION - Danaher designs, produces, and commercializes products as well as services catering to medical, professional, and commercial applications. The company functions through four major segments: life sciences, diagnostics, dental solutions, and environmental & applied solutions. Danaher’s diagnostics segment provides analytical instruments, reagents, consumables, software, and services for physicians’ offices, reference laboratories, hospitals, and other critical care spaces to diagnose numerous diseases. North America produced 38% of diagnostics share in 2016. Danaher’s facilities are situated in over 60 countries across the globe. Danaher accomplished acquisition of Leica Biosystems Nussloch GmbH in 2005. The company provides products across immunohistochemistry, surgery, digital pathology, clinical microscopy, in situ hybridization, and radiology; along with FISH, & histology equipment & consumables. 

• BECKMAN COULTER, INC - Beckman Coulter, Inc. was established as National Technical Laboratories. The company is involved in life sciences and diagnostics in about seven continents. It serves in hospitals, research institutes, quality control laboratories, and biopharmaceuticals. It also serves biopharmaceuticals by carrying out particle characterization. Beckman Coulter manufactures reagents and instruments for centrifugation, laboratory systems, flow cytometry, particle characterization, immunoassay, electrochemistry, hematology, spectrophotometry, and integrated systems. 

• CYTIVA - Cytiva is involved in supplying tools & services to biological research for the development of innovative biologic drugs, vaccines, and novel gene & cell therapies. This helps researchers to work faster, better, and safer, which leads to better outcomes. In addition, Cytiva provides technologies and services that accelerate and advance the drug development & manufacturing process. The company has a presence and operation in 40 countries, covering Europe, Asia, North & Latin America, and the Middle East region. In March 2020, the company joined Danaher Corporation and since then it operates as a part of Danaher’s life science business. 

• BIOMÉRIEUX SA - bioMérieux SA is a multinational biotechnology company that holds special forte in the sector of IVD for medical and industrial sectors. The company designs, creates, and mnaufactures diagnostic systems and offers diagnostic solutions such as instruments, reagents, and software. The company’s products are vastly used for diagnosing infectious diseases and testing for cardiovascular conditions and cancer screening & monitoring. At present, the company holds operations in over 150 countries through its distribution network and 42 subsidiaries. 

• QIAGEN - QIAGEN is a biotechnology-based company, globally operating in over 20 countries. Prime business areas of the company include pharmaceutical, assay technologies for molecular diagnostics, academic, as well as applied testing. The company’s product portfolio comprises a wide range of molecular testing applications. It markets over 500 products, including consumable kits and automation systems. Furthermore, molecular technologies created by the company are being used by forensic technicians. The company is also engaged in the isolation of genetic material from biological samples. Key customers include healthcare providers, pharmaceutical & biotechnology companies, government or industry customers, and researchers. 

• BECTON, DICKINSON & COMPANY (BD) - Becton, Dickinson & Company (BD) is a publicly owned company and operates in three business segments: BD Medical, BD Life Sciences, and BD Biosciences. The company specializes in microbiology solutions, genomics, drug delivery systems, and infection prevention. It possesses 20 brands and various integrated solutions in the field of healthcare. Currently, the company operates more than 190 countries worldwide, including North America, Latin America, Europe, Middle East & Africa, and Asia Pacific. 

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Tissue Diagnostics Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Tissue Diagnostics Market Report Assumptions:

• The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.